Improve Research Reproducibility A Bio-protocol resource
- Protocols
- Articles and Issues
- For Authors
- About
- Become a Reviewer
Lidia Jiménez-García
Unidad de Terapias Farmacológicas, Área de Genética Humana, Instituto de Investigación de Enfermedades Raras (IIER), Instituto de Salud Carlos III, Spain
Personal information
Education
M.S. in Pharmacy, University of Granada, 2012
Current position
Ph.D. student of Pharmacology Therapies Unit, Research institute for Rare diseases (IIER), Instituto de Salud Carlos III (ISCIII), Majadahonda, Madrid
Publications
-
Mota, A., Jimenez-Garcia, L., Herranz, S., de Las Heras, B. and Hortelano, S. (2015). alpha-Hispanolol sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis via death receptor up-regulation. Toxicol Appl Pharmacol 286(3): 168-177.
-
Jimenez-Garcia, L., Herranz, S., Luque, A. and Hortelano, S. (2015). Critical role of p38 MAPK in IL-4-induced alternative activation of peritoneal macrophages. Eur J Immunol 45(1): 273-286.